SGIOY:OTCMKTS
Shionogi 2 ADR Representing 1 Ord Shs
9,20Â US$
arrow_upward
+0,74%(+0,068) 1D
16 tet, 2:41:12 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për SGIOY...
Hap
9,36Â US$
I lartë
9,36Â US$
I ulët
9,19Â US$
Kapitalizimi i tregut
2,61Â bln
Vëllimi mesatar
175,16 mijë
Vëllimi
123,04 mijë
Maksimumi 52-javor
12,00Â US$
Minimumi 52-javor
7,83Â US$
Beta
0,07
Aksionet në qarkullim
1,78Â mld
Numri i punonjësve
6 mijë
Hap
9,36Â US$
I lartë
9,36Â US$
I ulët
9,19Â US$
Kapitalizimi i tregut
2,61Â bln
Vëllimi mesatar
175,16 mijë
Vëllimi
123,04 mijë
Maksimumi 52-javor
12,00Â US$
Minimumi 52-javor
7,83Â US$
Beta
0,07
Aksionet në qarkullim
1,78Â mld
Numri i punonjësve
6 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
23 orë më parë
Jefferies sets JPY 3,900.00 target for Shionogi stock
Profili
Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana.
Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines.
In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan.
Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV.
The company is listed on the Tokyo Stock Exchange and Osaka Securities Exchange and is constituent of the Nikkei 225 stock index.
In June 2023, Shionogi announced its acquisition of Qpex Biopharma for approximately $140m.
On 5 October 2026, Shionogi announced an agreement to acquire IntraBio for US$2 billion through its US subsidiary, Shionogi Inc. Wikipedia
Rreth Shionogi 2 ADR Representing 1 Ord Shs
Drejtori ekzekutivIsao Teshirogi
Punonjësit6,22 mijë
Themeluar më1878
Selia-
Sektori-
Uebsajtishionogi.com